Takeover

Acquirers

Yunfeng Capital, TF Capital, Velvet Investment

Targets
1
Filings
1
Median premium
98%
First filing
Oct 9, 2020
Latest filing
Oct 9, 2020

Targets

CompanyScore before dealScore nowFilingsLatest
Cellular Biomedicine Group, Inc.——1Oct 9, 2020

Deal filings

FiledCompanyFormPricePremium
Oct 9, 2020Cellular Biomedicine Group, Inc.PREM14A$19.7597.5%